9
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Enhancement of Protein Kinase C-mediated EGF Receptor Phosphorylation by Auranofin

, &
Pages 281-285 | Received 19 Aug 1987, Published online: 12 Jul 2009
 

Abstract

The lipophilic anti-inflammatory and immunoregulatory gold (I) complex, 2,3,4,6-tetra-O-acetyl-l-thio-β-D-glucopyranosato-S-[triethylphosphine] gold (auranofin) is now widely used in the treatment of rheumatoid arthritis (1). Although the specific biochemical action(s) of auranofin are not known, the drug has been shown to react readily with thiol groups (2). Such interactions may alter the activity of key enzymes either by direct involvement with the catalytic site or through allosteric effects. Several reports have indicated that auranofin can modulate cellular activation responses which involve the Ca2+-activated, phospholipid-dependent protein kinase (PKC). For example, low concentrations of auranofin (< 1 μM) enhance–and higher concentrations inhibit–the production of superoxide in neutrophils incubated with phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA), a known activator of PKC (3).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.